Author(s): LI Dong-feng, WANG Yu-bo, YANG Mei-ying, WANG Jian-hua, Dept. of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University
Pages: 495-497
Year: 2014 Issue:  6
Journal: China Pharmacy
Keyword:  Antineoplastic drugs; DDDs; Analysis of drug use;
Abstract: OBJECTIVE:To evaluate the clinical use of antineoplastic drugs in our hospital during 2010-2012. METHODS: The utilization of antineoplastic drugs in our hospital during 2010-2012 was analyzed retrospectively in terms of consumption sum and DDDs. RESULTS:The proportion of consumption sum of antineoplastic drugs in total consumption sum increased year by year;that of other types of antineoplastic drugs ranked in the first in these all three years. Consumption sum of paclitaxel and docetaxel as the first-line drugs both ranked in the top three from 2010 to 2012. The front of DDDs list was platinum,Chinese patent medicine and plant-source antitumor medicine and its derivatives. CONCLUSIONS:The clinical use of antineoplastic drugs in our hospital is in accordance with the situation and trend of treatment of malignant tumors in China.